GRP
NBIX icon

Global Retirement Partners’s Neurocrine Biosciences NBIX Stock Holding History

Global Retirement Partners’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$341K Buy
2,407
+2,231
+1,268% +$323K 0.01% 1167
2025
Q3 		$24.7K Buy
176
+30
+21% +$4.07K ﹤0.01% 2294
2025
Q2 		$18.4K Buy
+146
New +$16.7K ﹤0.01% 2335
2024
Q4 		$18K Sell
132
-7
-5% -$866 ﹤0.01% 2143
2024
Q3 		$16K Sell
139
-13
-9% -$1.78K ﹤0.01% 2101
2024
Q2 		$20.9K Sell
152
-40
-21% -$5.49K ﹤0.01% 1960
2024
Q1 		$26.5K Buy
192
+8
+4% +$1.09K ﹤0.01% 1689
2023
Q4 		$24.4K Sell
184
-87
-32% -$10K ﹤0.01% 1663
2023
Q3 		$30K Buy
271
+13
+5% +$1.37K ﹤0.01% 1493
2023
Q2 		$24.3K Buy
258
+147
+132% +$14.4K ﹤0.01% 1592
2023
Q1 		$10.9K Buy
111
+5
+5% +$520 ﹤0.01% 1889
2022
Q4 		$12.7K Sell
106
-5
-5% -$586 ﹤0.01% 1688
2022
Q3 		$13K Buy
111
+103
+1,288% +$10.5K ﹤0.01% 1581
2022
Q2 		$1K Hold
8
– – ﹤0.01% 2489
2022
Q1 		$1K Buy
+8
New +$678 ﹤0.01% 2456
2021
Q1 		– Sell
-19
Closed -$2K – 1854
2020
Q4 		$2K Buy
+19
New +$1.83K ﹤0.01% 1617

Other funds holding NBIX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Global Retirement Partners's NBIX Position: Q4 2025 in Review

Global Retirement Partners increased its Neurocrine Biosciences (NBIX) stake by 1,268% in Q4 2025, buying an estimated $323K and bringing the position to 2,407 shares worth $341K. The position accounts for 0.01% of the portfolio, ranked #1167.

Global Retirement Partners first reported a position in NBIX in Q4 2020 and has held it in 16 quarters since. 730 funds tracked by Wall St. Rank hold NBIX as of Q4 2025.

  • Global Retirement Partners held 2,407 shares of Neurocrine Biosciences worth $341K as of Q4 2025.
  • Global Retirement Partners bought 2,231 Neurocrine Biosciences shares in Q4 2025, an estimated $323K.
  • Neurocrine Biosciences made up 0.01% of Global Retirement Partners's portfolio in Q4 2025, its #1167 holding.
  • Global Retirement Partners first reported a position in Neurocrine Biosciences in Q4 2020 and has held it in 16 quarters since.
  • 730 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q4 2025.

Based on Global Retirement Partners's 13F filing for Q4 2025, filed 6 Feb 2026.